Trends in the choice of antiseizure medications in juvenile myoclonic epilepsy: A retrospective multi-center study from Turkey between 2010 and 2020

Kilic, Betul; SERDAROĞLU, ESRA; Polat, Burcin; Ince, Tugce; ESENÜLKÜ, GÜLNUR; Topcu, Yasemin; SERDAROĞLU, AYŞE; HASPOLAT, ŞENAY; TEKGÜL, HASAN; OKUYAZ, ÇETİN; CANSU, ALİ; Aydin, Kursad

doi:10.1016/j.seizure.2022.05.005

Trends in the choice of antiseizure medications in juvenile myoclonic epilepsy: A retrospective multi-center study from Turkey between 2010 and 2020

Copy For Citation

Kilic B., SERDAROĞLU E., Polat B. G., Ince T., ESENÜLKÜ G., Topcu Y., ...More

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, vol.99, pp.48-53, 2022 (SCI-Expanded)

Publication Type: Article / Article
Volume: 99
Publication Date: 2022
Doi Number: 10.1016/j.seizure.2022.05.005
Journal Name: SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE, Psycinfo
Page Numbers: pp.48-53
Keywords: juvenile myoclonic epilepsy, valproic acid, levetiracetam, LEVETIRACETAM, VALPROATE, MONOTHERAPY, MANAGEMENT
Karadeniz Technical University Affiliated: Yes

Abstract

Purpose:Valproic acid (VPA) is frequently used and effective in juvenile myoclonic epilepsy (JME). Recently, levetiracetam (LEV) has been suggested as a monotherapy in JME. This study aimed to evaluate antiseizure medication (ASM) use in patients with JME.